Alison Palmer Selected Research

Vascular Diseases (Vascular Disease)

9/2009

The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alison Palmer Research Topics

Disease

5	Myocardial Infarction 09/2009 - 02/2003
3	Coronary Disease (Coronary Heart Disease) 08/2006 - 02/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2007 - 02/2003
1	Non-Muscle Invasive Bladder Neoplasms 01/2019
1	Transitional Cell Carcinoma 01/2019
1	Vascular Diseases (Vascular Disease) 09/2009
1	Obesity 09/2009
1	Inflammation (Inflammations) 04/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2007
1	Cardiotoxicity 02/2003

Drug/Important Bio-Agent (IBA)

3	ApolipoproteinsIBA 09/2009 - 02/2003
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2009 - 07/2007
2	HDL CholesterolIBA 09/2009 - 07/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2009 - 07/2007
2	LipidsIBA 07/2007 - 10/2004
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019
1	Celecoxib (Celebrex)FDA Link 01/2019
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2019
1	Apolipoproteins AIBA 09/2009
1	Apolipoproteins B (ApoB)IBA 09/2009
1	oxidized low density lipoproteinIBA 09/2009
1	LDL CholesterolIBA 09/2009
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2008
1	lipoprotein cholesterolIBA 07/2007
1	CholesterolIBA 07/2007
1	Fibrinogen (Factor I)FDA Link 08/2006
1	Lymphotoxin-alpha (Lymphotoxin)IBA 07/2006
1	Apolipoproteins E (ApoE)IBA 02/2003
1	Apolipoprotein E2IBA 02/2003

Therapy/Procedure

2	Therapeutics 01/2019 - 07/2007